Column Capital Advisors’s Bio-Techne TECH Stock Holding History

Column Capital Advisors’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$49.6K	Sell	728 -4	-0.5%	-$316	0.01%	324
2023 Q2	$59.8K	Hold	732	–	–	0.01%	303
2023 Q1	$54.3K	Hold	732	–	–	0.01%	311
2022 Q4	$60.7K	Hold	732	–	–	0.01%	273
2022 Q3	$52K	Hold	732	–	–	0.01%	269
2022 Q2	$63K	Buy	732 +132	+22%	+$12.4K	0.01%	240
2022 Q1	$65K	Hold	600	–	–	0.01%	261
2021 Q4	$78K	Sell	600 -16	-3%	-$1.96K	0.02%	234
2021 Q3	$75K	Sell	616 -176	-22%	-$21.4K	0.02%	217
2021 Q2	$89K	Sell	792 -132	-14%	-$13.9K	0.02%	199
2021 Q1	$88K	Sell	924 -236	-20%	-$21.5K	0.02%	194
2020 Q4	$92K	Hold	1,160	–	–	0.02%	180
2020 Q3	$72K	Hold	1,160	–	–	0.02%	192
2020 Q2	$76K	Sell	1,160 -264	-19%	-$15.8K	0.03%	186
2020 Q1	$68K	Hold	1,424	–	–	0.03%	165
2019 Q4	$78K	Buy	+1,424	New	+$74.7K	0.04%	174

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Column Capital Advisors's TECH Position: Q3 2023 in Review

Column Capital Advisors reduced its Bio-Techne (TECH) stake by 0.55% in Q3 2023, selling an estimated $316 and leaving 728 shares worth $49.6K. The position accounts for 0.01% of the portfolio, ranked #324.

Column Capital Advisors first reported a position in TECH in Q4 2019 and has held it in 16 quarters since. The position peaked at $92K in Q4 2020. 530 funds tracked by Wall St. Rank hold TECH as of Q3 2023.

Column Capital Advisors held 728 shares of Bio-Techne worth $49.6K as of Q3 2023.
Column Capital Advisors sold 4 Bio-Techne shares in Q3 2023, an estimated $316.
Bio-Techne made up 0.01% of Column Capital Advisors's portfolio in Q3 2023, its #324 holding.
Column Capital Advisors first reported a position in Bio-Techne in Q4 2019 and has held it in 16 quarters since.
Column Capital Advisors's Bio-Techne position peaked at $92K in Q4 2020.
530 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2023.

Based on Column Capital Advisors's 13F filing for Q3 2023, filed 3 Nov 2023.